TP53 and cancer: While these studies indicate that CRISPR-Cas9 genome editing techniques may select for p53-mutated cells13–15, several outstanding questions remain unaddressed: First, since most of these p53 studies have involved only a small number of primary or transformed cells13,14, it is unclear whether p53 selection can happen broadly across multiple different cell types including transformed cancer cells.